Induction DX2

Receptor-Mediated Apoptosis in Human Cells Using anti-Fas/CD95 (Clone DX2)

Materials Required

  1. A cell line (eg, Jurkat T cells, ATCC TIB 152) or primary cells that can be induced to undergo apoptosis by human Fas mAb.
  2. Anti-human Fas mAb, Clone DX2 (Cat. No. 555670).
  3. Recombinant Protein G (SIGMA, Cat. No. P4689). The addition of Protein G to the tissue culture medium can significantly enhance the efficiency of DX2 mAb to induce apoptosis, presumably by cross-linking.
  4. Tissue culture flasks or tissue culture plates.
  5. RPMI-1640 medium supplemented with 10% heat- inactivated fetal bovine serum (FBS), 1% L-glutamine and 1% antibiotics (penicillin/streptomycin; 100 U/ml). This supplemented medium is referred to as 'medium' below.

Protocol

  1. Induction of apoptosis: treat cell suspension (0.5-1 x 10 6 cells/ml) with anti-CD95, clone DX2 (titrate 2-20 µg/ml to determine optimal concentration), and 2 µg/ml Protein G. Negative controls should consist of cells with medium alone (no mAb or Protein G) and cells with medium and Protein G (no mAb).
  2. Perform a time course to obtain optimum results. An incubation time of 2-16 hr at 37°C is suggested.
  3. Proceed with assays designed to evaluate induction of apoptosis.

This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience.